Adverse drug reaction: pomalidomide-induced liver injury

Survival after multiple myeloma has improved with the use of immunomodulatory drugs--thalidomide, lenalidomide, and pomalidomide. Pomalidomide, the latest immunomodulatory drug to be approved by the US Food and Drug Administration, was developed by modifying thalidomide's chemical structure to...

Full description

Saved in:

Bibliographic Details
Published in:	The Lancet (British edition) Vol. 383; no. 9935; pp. 2125 - 2126
Main Authors:	Veluswamy, Rajwanth R, Ward, Stephen C, Yum, Kendra, Abramovitz, Rebecca B, Isola, Luis M, Jagannath, Sundar, Parekh, Samir
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 21-06-2014 Elsevier Limited
Subjects:	Chemical and Drug Induced Liver Injury - etiology Chemotherapy Drug dosages Hepatotoxicity Humans Internal Medicine Liver Male Middle Aged Multiple myeloma Multiple Myeloma - therapy Side effects Stem Cell Transplantation Stem cells Thalidomide - adverse effects Thalidomide - analogs & derivatives Transplants & implants
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!